Joint Program Committee 1 (JPC-1) – Medical Simulation and Information Sciences Research Program (MSIS)Translational Simulation Research (TRANSfeR) Award
http://www.grants.gov/search-grants.html?agencyCode%3DDOD, Keyword: TRANSfeR
A. Program Description
Applications to the Fiscal Year 2017 (FY17) Joint Program Committee-1 (JPC-1)/Medical Simulation and Information Sciences (MSIS) Research Program are being solicited for the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate, by the U.S. Army Medical Research Acquisition Activity (USAMRAA). As directed by the Office of the Assistant Secretary of Defense for Health Affairs (OASD[HA]), the DHA RDA Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The U.S. Army Medical Research and Materiel Command (USAMRMC) Congressionally Directed Medical Research Programs (CDMRP) provides Defense Medical Research and Development Program (DMRDP) management support for DHP core research program areas, including the JPC-1/MSIS. This Program Announcement/Funding Opportunity and subsequent awards will be managed by CDMRP with strategic oversight from the JPC-1/MSIS.The JPC-1/MSIS Medical Simulation and Training Steering Committee provides programmatic funding recommendations for DHP medical RDT&E dollars related to medical training and education efforts to advance the development and integration of simulation-based training systems. The JPC-1/MSIS Medical Simulation and Training Steering Committee provided the strategy for which this Program Announcement/Funding Opportunity’s topic was conceived.The mission of the JPC-1/MSIS is to explore the implications of models and technology for medical education and training plus for the provision, management, and support of health services in the military. The JPC-1/MSIS plans, coordinates, and oversees a responsive world-class, tri-Service science and technology program focused on two areas of research. One area is focused on improving military medical training through medical modeling, simulation, and educational training tools. The second area is focused on improving the use and sharing of health-related data for better strategic planning, process development, and software applications.
B. Medical Readiness Initiative (MRI): Translational Simulation Research (TRANSfeR): Medical Simulation Modeling to Assess Translation Skills from Training to Clinical Practice
The Translational Simulation Research (TRANSfeR): Medical Simulation Modeling to Assess Translation Skills from Training to Clinical Practice is a line of research that supports the Medical Readiness Initiative (MRI) under the JPC-1/MSIS Medical Simulation and Training portfolio. The JPC-1/MSIS MRI focuses on the research and development (R&D) of medical training methods, technologies, systems, and competency assessment tools for the attainment and sustainment of military medical readiness R&D efforts. MRI also includes methodologies, techniques, and tools that will allow for ethical, accurate, and appropriate pre-intervention rehearsal with input of potential authorized personal medical information into simulation models. Evidence-based efforts with measurable outcomes and reliable assessments also fall under the MRI. The outcomes of the research are intended to be used to support the solution assessments/material considerations for guidelines or curriculum development of TRANSfeR foundation concepts. The research outcomes will be used in assessing critical technology elements and technology maturity, system integration risk, future manufacturing feasibility, and, where necessary, technology maturation and demonstration needs.
For more inquiries go to the CDMRP Help desk at help@eBRAP.org or call 301-682-5507.
SUBMISSION AND REVIEW DATES AND TIMES
• Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), October 13, 2016
• Invitation to Submit an Application: November 22, 2016
• Application Submission Deadline: 5:00 p.m. ET, February 2, 2017
• End of Application Verification Period: 5:00 p.m. ET, February 8, 2017
• Peer Review: April 2017
• Programmatic Review: May 2017